Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Alkem Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 2,117.05 17.30  | 0.82% 8.71% 27.29 25,271.86
NSE Price: Nov 19, 15:57 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 19, 15:57 2,117.05 17.30 0.82% 2,119.35 2,099.75 78,374 2,100.00 - 2,150.00
BSE Nov 19, 2019 2,113.65 14.10 0.67% 2,101.00 2,099.55 1,864 2,101.00 - 2,149.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue7,892.767,357.196,391.845,687.534,924.84 3,743.353,126.00
Other Income85.9087.70115.42112.01239.71 181.04165.35
Total Income7,978.667,444.896,507.265,799.545,164.55 3,924.393,291.35
Total Expenditure6,628.886,242.425,382.924,688.584,071.59 3,321.522,716.05
Operating Profit1,349.781,202.471,124.341,110.961,092.96 602.87575.30
Interest55.8454.6355.3345.1671.24 81.1193.08
PBDT1,293.941,147.841,069.011,065.801,021.72 521.76482.22
Depreciation217.19193.18143.03101.1793.31 70.9452.26
PBT & Exceptional Items1,076.75954.66925.98964.63928.41 450.82429.96
Exceptional Items0.00---- --
Profit before Tax1,076.75954.66925.98964.63928.41 450.82429.96
Provision for Tax132.99181.02287.5659.96176.18 59.23-5.36
Profit after Tax943.76773.64638.42904.67752.23 391.59435.32
Minority Interest-17.55-13.13-7.48-12.64-10.64 --
Share of Associate0.00---- --
Consolidated Profit926.21760.51630.94892.03741.59 391.59435.32
 
LiabilitiesR Cr
Share Capital23.9123.9123.9123.9123.91 23.9111.96
Total Reserves5,851.405,413.934,838.874,443.343,668.03 2,978.722,573.01
Shareholder's Funds5,875.315,439.344,863.774,467.643,691.96 3,002.632,584.97
Minority Interest140.92132.61121.55115.2395.02 85.65-
Long Term Borrowings333.69231.30130.73181.56123.46 33.43232.25
Other Non Current Liabilities240.34214.42164.60113.4685.61 163.5991.67
Current Liabilities2,564.172,190.222,383.311,689.691,537.60 2,005.981,402.58
Total Debt*-944.07997.56659.46657.50 1,305.921,128.43
Total Liabilities9,154.438,207.897,663.966,567.585,533.65 5,291.284,311.47
 
AssetsR Cr
Net Block2,199.162,530.442,283.591,797.041,449.54 1,374.341,170.01
Non Current Investments98.8295.7498.45259.44234.39 419.73338.24
Other Non-Current Assets1,947.481,365.581,268.701,593.961,081.02 1,159.161,201.08
Current Investments215.98227.88345.82293.56274.18 61.05249.77
Cash and Bank962.53661.60576.78399.26780.90 790.76206.29
Other Current Assets3,730.463,326.653,090.622,224.321,713.62 1,486.241,146.08
Net Current Assets2,344.802,025.911,629.911,227.451,231.10 332.07199.56
Miscellaneous Exp. Not Written Off----- --
Total Assets9,154.438,207.897,663.966,567.585,533.65 5,291.284,311.47
 
Cash FlowR Cr
From Operations-777.41266.04471.14725.83 325.47290.01
From Investing Activities--314.15-357.23-285.93202.27 -236.97350.44
From Finance Activities--378.9484.56-137.88-927.27 -51.78-599.94
Net Inflow/Outflow-84.32-6.6347.330.83 36.7240.51
 
Key Ratios
Adjusted EPS (Rs)77.4763.6152.7874.6262.03 32.7636.40
Adjusted Book Value (Rs)491.39454.86406.76373.67308.82 251.16216.13
Dividend per Share (Rs)-16.0013.0015.0012.70 4.004.00
Cash Flow per Share (Rs)-65.0322.2539.4160.71 27.22242.48
Debt to Equity0.060.170.210.150.18 0.430.44
Current Ratio1.911.921.681.731.80 1.171.14
ROCE (%)-16.4917.8621.3123.09 13.2614.06
RONW (%)17.0015.0213.6922.1822.47 14.0218.28
Operating Margin (%)17.1016.3417.5919.5322.19 16.1118.40
Net Margin (%)11.8310.399.8115.6014.57 9.9813.23
Revenue Growth (%)15.8815.1012.3815.4931.56 19.7525.28
Net Profit Growth (%)46.3421.18-29.4320.2792.10 -10.0513.47
EPS Growth (%)47.1720.54-29.2720.2989.38 -10.0113.42
Book Value Growth (%)-11.838.8521.0022.96 16.1618.72
 
Market Cues
Close Price (Rs)2,117.051,750.851,988.352,204.901,356.45 --
High Price (Rs)2,150.002,268.002,469.002,227.951,588.90 --
Low Price (Rs)1,660.001,690.001,578.301,152.501,227.00 --
Market Cap (Rs Cr)25,271.8620,942.7723,635.0426,384.0916,336.51 0.000.00
Price / Earnings27.2927.5437.4629.5822.03 0.000.00
Price / Book Value4.303.854.865.914.42 0.000.00
Dividend Yield (%)0.760.910.660.680.93 --
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
8.39
Piotroski F-Score
8
Modified C-Score
0
3-Years Price to Earnings
27.29
3-Years Price to Book
4.30
Earnings Yield
EBIT / Enterprise value
4.47%
PEG
Price / Earnings to growth ratio
5.15
Related Stocks
  Current Price   Chng %
Abbott India R12,785.15 -0.24%
Aurobindo Pharma R431.20 +1.42%
Bayer CropScience R3,709.25 +3.42%
Biocon R258.55 -0.75%
Cadila Healthcare R243.70 +0.91%
Glaxosmithkline Pharma R1,639.85 +0.70%
Lupin R747.70 +0.15%
Pfizer R4,053.95 -0.41%
Piramal Enterprises R1,761.35 +0.94%
Torrent Pharmaceuticals R1,759.05 -1.13%
As on Nov 19, 15:59